Login
Israel-Hamas Conflict
Motorsports
Social Media
Natural Disasters
Floods
World Cup
Artificial Intelligence
Education
BRICS
Independence Day
Wrestling
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

How a Big Pharma veteran looks to stand out in biotech as a unique ‘drug hunter’

Summary by PharmaVOICE
J&J’s former head of R&D, now CEO of Parabilis Medicines, aims to remain above the biotech fray by taking on unique targets from which others have steered clear.

1 Articles

All
Left
Center
1
Right
PharmaVOICEPharmaVOICE
Center

How a Big Pharma veteran looks to stand out in biotech as a unique ‘drug hunter’

J&J’s former head of R&D, now CEO of Parabilis Medicines, aims to remain above the biotech fray by taking on unique targets from which others have steered clear.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PharmaVOICE broke the news in on Tuesday, June 24, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Pharma icon

Pharma

Johnson & Johnson icon

Johnson & Johnson

United States icon

United States

You have read 1 out of your 5 free daily articles.

News
For You
SearchBlindspotLocal